CD19 and autoimmune disease: CD19 and BCMA-specific CAR T cells are also being repurposed for the treatment of autoimmune diseases, where autoreactive cells of the B cell lineage (B cells themselves, plasmablasts, and plasma cells) are central mediators of disease pathology (14, 15).